Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-10-025350

Options or other derivatives

  • Chief Medical Officer acquired 900,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BARTLETT ROBERT HAWES Chief Medical Officer 2010-05-05 Grant or award · Stock Option +900,000 1,125,000 D: show line 1 in the form
Loading xslF345X03/v183945_ex.xml…